Pidnarulex

TAIPEI, Taiwan — August 25, 2026 Senhwa Biosciences announced that it has completed patient enrollment in its Phase 1b...

TAIPEI, Taiwan & SAN DIEGO, Calif., July 14, 2026 Senhwa Biosciences, Inc. has entered into a significant financing agreement...

Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has...